{"id":869903,"date":"2026-10-03T23:50:23","date_gmt":"2026-10-03T23:50:23","guid":{"rendered":"https:\/\/www.newsbeep.com\/us\/869903\/"},"modified":"2026-10-03T23:50:23","modified_gmt":"2026-10-03T23:50:23","slug":"new-albany-lands-bayer-campus-with-innovative-pharmaceutical-facility","status":"publish","type":"post","link":"https:\/\/www.newsbeep.com\/us\/869903\/","title":{"rendered":"New Albany lands Bayer campus with innovative pharmaceutical facility"},"content":{"rendered":"<p>NEW ALBANY, Ohio (WSYX) \u2014 Bayer plans to invest $2.2 billion to build a new pharmaceutical manufacturing campus in New Albany, creating about 600 permanent jobs and 1,500 construction jobs as Ohio expands its life sciences and biomanufacturing industries.<\/p>\n<p>The 200-acre campus will be built at the New Albany International Business Park. Ohio Gov. Mike DeWine, who joined Bayer and JobsOhio officials Friday to announce the project, called the project a historic investment in the state and said its impact extends beyond pharmaceuticals, pointing to biomanufacturing&#8217;s connection to agriculture.<\/p>\n<p>\u201cSome people might be surprised that they&#8217;re also means a lot of different things in agriculture,\u201d DeWine said. \u201cWe&#8217;re very proud to have this company here in Ohio. As you heard, when they go someplace, they stay a long time. This is going to have benefit for people in the state of Ohio for 50 to 100 years.\u201d<\/p>\n<p>DeWine said the investment is another sign of Ohio&#8217;s growing strength in health sciences and biomanufacturing and emphasized the state&#8217;s efforts to develop the workforce needed to support the industry.<\/p>\n<p>The 600 permanent jobs will focus on manufacturing the compounds that make medicines work. Bayer officials said the new campus will combine drug substance and drug product manufacturing and use advanced digital and automation technologies.<\/p>\n<p>The facility will support Bayer&#8217;s work in developing and manufacturing medicines for conditions including cancer, heart disease and kidney disease. Bayer CEO Bill Anderson said the company took the decision seriously because the investment will affect generations of workers and patients.<\/p>\n<p>For Anderson, the announcement also marked a homecoming. He was born in Cleveland, and said the company is known around the world for products including Aspirin.<\/p>\n<p>\u201cBayer is synonymous with Aspirin, but we&#8217;re focused on what&#8217;s next,\u201d Anderson said. \u201cWhat&#8217;s next will go through New Albany.\u201d<\/p>\n<p>The project builds on more than $7 billion Bayer says it has spent on U.S. pharmaceutical research and manufacturing during the past five years.<\/p>\n<p>Anderson said the new campus will be designed as a flexible and modular facility, allowing Bayer to expand its manufacturing capabilities as its pharmaceutical portfolio grows.<\/p>\n<p>The investment also will draw on Ohio&#8217;s workforce training infrastructure.<\/p>\n<p>The Ohio Life Science Training Center is expected to open in summer 2027 and will prepare Ohioans to work as biomanufacturing operators and technicians. JobsOhio is contributing $30 million toward the center, with additional funding from the city of New Albany, the state and private partners.<\/p>\n<p>JobsOhio President and CEO J.P. Nauseef said the investment demonstrates the importance of Ohio&#8217;s workforce to Bayer&#8217;s decision.<\/p>\n<p>\u201cBayer didn&#8217;t just choose a site. It chose a workforce,\u201d Nauseef said.<\/p>\n<p>U.S. Sen. Bernie Moreno said the jobs created by Bayer will not be limited to workers with advanced scientific degrees.<\/p>\n<p>\u201cBayer&#8217;s going to have the smartest scientists on the planet that are working right here in Columbus, Ohio, but they&#8217;re also going to need people of all different skill sets,\u201d Moreno said. \u201cAnd that&#8217;s what&#8217;s really out there for people watching this. This is a job where you can come in with no skill sets, come here, get upskilled, go to Bayer and someday be the CEO.\u201d<\/p>\n<p>U.S. Rep. Joyce Beatty, whose district includes the project, called the investment significant for Central Ohio and highlighted its potential to create opportunities for local families.<\/p>\n<p>\u201cThis is a big investment for my district and for Central Ohio,\u201d Beatty said. \u201cBayer&#8217;s $2 billion investment means 600 new jobs and more opportunities for our families.\u201d<\/p>\n<p>Beatty also pointed to Bayer&#8217;s existing connections with Ohio&#8217;s research and health care institutions and the potential for the project to strengthen the state&#8217;s life sciences sector.<\/p>\n<p>New Albany Mayor Sloan Spalding said the project builds on momentum created by the region&#8217;s growing life sciences cluster, which includes companies such as Amgen, American Regent, Hims &amp; Hers and Pharmavite.<\/p>\n<p>The Bayer campus also is expected to strengthen connections between pharmaceutical manufacturing, academic research and Ohio&#8217;s workforce development efforts.<\/p>\n<p>The new operation will complement Bayer&#8217;s U.S. pharmaceuticals headquarters in New Jersey and other sites across the country.<\/p>\n<p>Jeffrey Kessler, undersecretary of commerce for industry and security at the U.S. Department of Commerce, represented the Trump administration at the announcement. He said expanding domestic pharmaceutical manufacturing is important to the country&#8217;s ability to produce lifesaving medicines.<\/p>\n<p>The project is expected to pursue a Job Creation Tax Credit through the Ohio Department of Development and seek assistance from JobsOhio, with additional details to be announced after agreements are finalized.<\/p>\n<p>The first Bayer manufacturing module in New Albany is expected to open in 2031, with the second module planned for 2034.<\/p>\n","protected":false},"excerpt":{"rendered":"NEW ALBANY, Ohio (WSYX) \u2014 Bayer plans to invest $2.2 billion to build a new pharmaceutical manufacturing campus&hellip;\n","protected":false},"author":2,"featured_media":869904,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[59],"tags":[97,252,253],"class_list":["post-869903","post","type-post","status-publish","format-standard","has-post-thumbnail","category-health-care","tag-health","tag-health-care","tag-healthcare"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/869903","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/comments?post=869903"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/posts\/869903\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media\/869904"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/media?parent=869903"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/categories?post=869903"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/us\/wp-json\/wp\/v2\/tags?post=869903"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}